A cure for cancer could be on the horizon in the next decade, according to experts. Johnson & Johnson Chairman and CEO Joaquin Duato reflected on the pharmaceutical company’s projections on the future of cancer treatment during the WSJ Leadership Institute CEO Summit in London.

Cancer Treatment Progress

Duato shared that the goal is to “try to eliminate cancer” in the next 10 years. He used multiple myeloma as an example, noting that life expectancy is currently 10 years, when it was previously “only single years.” Duato also mentioned that Johnson & Johnson is working to understand the biology of cancer growth and to formulate new technologies to address it.

According to Duato, it’s realistic to believe that certain cancers will be cured, and some others will be turned into chronic diseases. Fox News senior medical analyst Dr. Marc Siegel agreed with Duato’s outlook on the future of cancer care, noting that certain cancers will turn into chronic diseases while others will find outright cures.

Original reporting: Fox News (HLL/CB) — read the source article.